Saturday 17 October 2026
Export SOLS’s income statement to Excel — free account
Solstice Advanced Materials Inc.
SOLS Basic Materials Specialty Chemicals
Solstice Advanced Materials Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 3.08% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS fell 15.0%, free cash flow grew 70.8% and total debt rose 5,486.5%, each against the same quarter a year earlier.
59.25
0.67
−1.12%
Follow SOLS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+5 more quarters Free account |
33.17 | 33.17 | 33.17 | 40.95 |
P/S ratio |
2.02 | 1.98 | 3.04 | 3.44 | |
P/FCF ratio |
31.48 | 54.29 | 83.41 | 80.40 | |
P/Operating CF |
(365.77) | 46.44 | 60.77 | 53.70 | |
P/B ratio |
2.41 | 5.60 | 8.21 | 8.86 | |
Price to Tangible BV |
3.31 | 15.18 | 19.96 | 19.43 | |
EV/Sales |
1.94 | 2.38 | 3.40 | 3.76 | |
EV/EBITDA |
8.31 | 11.08 | 16.57 | 19.02 | |
EV/Operating CF |
13.07 | 20.33 | 27.37 | 25.39 | |
EV/FCF |
30.21 | 65.15 | 93.26 | 87.92 | |
Quick Ratio |
0.86 | 0.69 | 0.75 | 0.81 | |
Current Ratio |
1.53 | 1.39 | 1.43 | 1.46 | |
Net Debt/EBITDA |
(1.63) | 10.35 | 6.62 | 5.16 | |
Debt/Assets |
2.06% | 36.59% | 36.03% | 34.93% | |
Debt/Equity |
0.03 | 1.51 | 1.41 | 1.30 | |
Asset Turnover |
1.45 | 1.37 | 1.38 | 1.38 | |
Operating CF/Net income |
0.60 | 4.05 | 2.34 | 2.20 | |
Capex/Depreciation |
(2.20) | (1.93) | (1.29) | (2.40) | |
Interest Coverage |
69.50 | 4.13 | 5.41 | 8.57 | |
Research and Development Expense of Revenue |
2.68% | 2.63% | 2.83% | 2.18% | |
Selling, General and Administrative Expense of Revenue |
11.66% | 11.14% | 10.90% | 10.71% | |
Intangible Assets out of Total Assets |
0.16 | 0.15 | 0.15 | 0.15 | |
Share Based Compensation of Revenue |
0.72% | 0.81% | 0.50% | 0.52% | |
Graham Net Nets |
(0.02) | (0.25) | (0.15) | (0.13) | |
Graham Number |
0.00 | 0.00 | 21.89 | 22.06 | |
Earnings Yield |
3.01% | 3.01% | 3.01% | 2.44% | |
Free Cash Flow Yield |
3.18% | 1.84% | 1.20% | 1.24% | |
Revenue per Share |
0.00 | 6.22 | 6.24 | 7.23 | |
Operating CF per Share |
0.00 | 1.05 | 1.25 | 1.65 | |
Capex per Share |
0.00 | (0.66) | (0.48) | (0.88) | |
Free Cash Flow per Share |
0.00 | 0.39 | 0.77 | 0.77 | |
Cash per Share |
0.00 | 3.36 | 4.04 | 4.72 | |
Shareholders Equity per Share |
0.00 | 8.68 | 9.28 | 10.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 8.68 | 9.28 | 10.00 | |
Free Cash Flow |
(131.00) | 62.00 | 123.00 | 123.00 | |
Working Capital |
652.00 | 675.00 | 731.00 | 808.00 | |
Capital Expenditures |
(110.00) | (104.00) | (76.00) | (139.00) | |
Net Current Asset Value |
(188.00) | (1,908.00) | (1,839.00) | (1,762.00) | |
EV/EBIT |
10.22 | 15.04 | 22.77 | 26.17 | |
Capex to Sales |
0.11 | 0.11 | 0.08 | 0.12 | |
Price to Operating Income |
10.65 | 12.54 | 20.36 | 23.93 | |
| Other line items | |||||
Average Receivables |
— | — | — | 620.00 | |
Average Payables |
— | — | — | 860.00 | |
Average Inventory |
— | — | — | 612.00 | |
Average Assets |
2,623.50 | 2,836.50 | 2,874.00 | 2,959.00 | |
Average Common Equity |
— | — | — | 2,385.00 |
Columns are period end dates